MedPath

Diphenhydramine in Catheter Related Bladder Discomfort

Not Applicable
Conditions
Catheter Complications
Interventions
Registration Number
NCT06345261
Lead Sponsor
Cairo University
Brief Summary

Diphenhydramine has H1-antihistamine action, it also possesses anti-muscarinic properties. Thus, diphenhydramine might be able to reduce the problem of catheter related bladder discomfort by inhibiting smooth muscle spasm of the urinary bladder via its anti-muscarinic action .

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Male
Target Recruitment
104
Inclusion Criteria

male patients aged more than18-80 years ASA I and II , upper ureteric stone removal under general anesthesia r

Read More
Exclusion Criteria

overactive bladder cognitive impairment a neuropsychological disorder, bladder outflow obstruction urinary tract infection, , neurogenic bladder, operative time > 6 h

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diphenhydramine groupDiphenhydrAMINE 50 Mg/mL Injectable Solution-
control groupSaline-
Primary Outcome Measures
NameTimeMethod
incidence of catheter related bladder discomfort postoperativeUP TO 6 HOURE

* none, did not complain of any CRBD even upon asking.

* mild, revealed only on questioning.

* moderate, reported without questioning but not accompanied by any behavioral response.

* severe, stated on their own and followed by behavioral responses such as a strong verbal response, flailing limbs, and even attempting to pull out the urinary catheter

Secondary Outcome Measures
NameTimeMethod
visual analog scale (VAS)up to 6 hours

0 (no pain) to 10 (the worst imaginable pain)

Trial Locations

Locations (1)

Cairo university

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath